Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: FLARE

Treating to Target in Gout: The Trouble with Serum Urate

Samantha C. Shapiro, MD  |  July 21, 2022

New analyses of treat to target in gout may lead to revisions in some guidelines.

Filed under:ConditionsEULAR/OtherGout and Crystalline ArthritisMeeting Reports Tagged with:EULARGoutGout Resource CenterTreat-to-Target

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD  |  July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:belimumabEULARHCQHydroxychloroquine (HCQ)rituximabSLEsystemic lupus erythematosus (SLE)

Baricitinib Promising for Juvenile Idiopathic Arthritis

Michele B. Kaufman, PharmD, BCGP  |  July 19, 2022

In a study from Ramanan et al., baricitinib proved safe and effective for reducing the time to flare and frequency of flare in patients aged 2–18 years with juvenile idiopathic arthritis.

Filed under:ConditionsDrug UpdatesEULAR/OtherMeeting ReportsPediatric Conditions Tagged with:baricitinibEULARflareJIAjuvenile idiopathic arthritis (JIA)PediatricPediatric Rheumatology

Predicting the Future: Prognostication in Rheumatoid Arthritis

Jason Liebowitz, MD, FACR  |  July 19, 2022

A EULAR 2022 abstract session looked at several studies that seek to increase understanding of RA pathogenesis & identify patients at risk for disease progression.

Filed under:ConditionsEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:anti-advanced glycated end-products (anti-AGE) antibodiesanti-malondialdehyde-acetaldehyde (anti-MAA) antibodiesEULARRheumatoid Arthritis (RA)synovialTenosynovitis

Never Too Late: Late-Breaking Abstracts Create Excitement

Jason Liebowitz, MD, FACR  |  July 15, 2022

EULAR 2022 (VIRTUAL)—The pace of scientific progress in research medicine is incredible and seems to only accelerate with time. Thus, the 2022 Congress of the European Alliance of Associations for Rheumatology (EULAR) session on late-breaking abstracts fittingly captured the excitement and timeliness of a number of research projects that have just recently been completed and…

Filed under:ConditionsEULAR/OtherMeeting Reports Tagged with:baricitinibBimekizumabdeucravacitinibEULARjuvenile idiopathic arthritis (JIA)MethotrexateorelabrutinibPolymyalgia RheumaticaPsoriatic Arthritissarilumabsystemic lupus erythematosus (SLE)

A Prescription for Mindfulness

Dana DiRenzo, MD, MHS  |  July 13, 2022

The prescription is a powerful tool for a physician. As rheuma­tologists, we prescribe many things—drugs, physical therapy, durable medical equipment—but what about stress reduction? We are very specific about times of day to take medications and in what manner. Patients ask: With or without food? With other medications? Before or after other prescribed medications? If…

Filed under:AppsEducation & TrainingTechnology Tagged with:meditationmindfulnessself-managementStress

Zenobillis / shutterstock.com

Rheumatologists Share Lessons Learned in the Wake of Hurricane Ida

Susan Bernstein  |  July 13, 2022

Hurricane Ida intensified in the last two weeks of August 2021, battering the Cayman Islands and Cuba before hitting the Louisiana coast as a Category 4 storm just before Labor Day weekend.1 At landfall, Ida blasted southern Louisiana with maximum sustained winds of 150 knots, then turned in a north-northwestern direction to hit the New…

Filed under:EMRsFacilityPractice Support Tagged with:Disaster preparationNatural disaster

Challenges in Reproductive Health in Rheumatic Disease

Keri Losavio & Julie Nusbaum, MD  |  July 11, 2022

In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

Filed under:ConditionsDrug UpdatesMeeting ReportsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Access to Reproductive Health Care Task Forcedisease managementLegalMethotrexatepregnancyreproductive healthReproductive Health in Rheumatic Disease Symposium

How to Recognize an Autoinflammatory Disorder

Samantha C. Shapiro, MD  |  June 15, 2022

Autoinflammatory disorders may involve genetic mutations of the inflammasome or an environmental trigger in a genetically susceptible host. Dr. Jay Mehta discussed a practical, clinical approach to caring for patients with autoinflammatory disorders, such as periodic fever syndromes, during the 2022 ACR Education Exchange.

Filed under:ConditionsMeeting ReportsOther ACR meetingsOther Rheumatic Conditions Tagged with:ACR Education Exchangeautoinflammatory diseaseFamilial Mediterranean feverfeverInflammasomePeriodic fever syndromes

Gout Experts Share Insights Into a Variety of Challenging Gout Scenarios

Ruth Jessen Hickman, MD  |  June 14, 2022

Although the diagnosis and treatment of gout are sometimes straightforward, prac­titioners encounter challenges in patients with atypical presentations, as well as those with medically complex situations or refractory disease. Here, gout experts share insights into some of these scenarios. Flare in Hospitalized Patients When not contraindicated, the 2020 ACR Guideline for the Management of Gout…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:Flaresorgan transplantpegloticasepolyarticular arthritisrefractory gout

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 68
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences